Evidence for pathogenic heterogeneity in multiple sclerosis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Annals of Neurology

• Publication date

  2004-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ana.20182PMID 15293289
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion

  2004cited by this paper
• Discussion: Reconsideration of TIA terminology and definitions

  2004cited by this paper
• Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

  2000cited by this paper

• Fisiopatologia della sclerosi multipla

  2026cites this paper
• EBV reprograms autoreactive anti-CNS B cells as antigen presenting cells in multiple sclerosis

  2026cites this paper
• Advanced quantitative MRI reveals a unique pattern of metabolic alterations and iron-pathology linked to glial activation in Baló's concentric sclerosis.

  2025cites this paper
• Physiopathologie de la sclérose en plaques

  2025cites this paper
• Multiple Sclerosis: Inflammatory and Neuroglial Aspects

  2023cites this paper
• Long‐term clinical, imaging and cognitive outcomes association with MS immunopathology

  2023cites this paper
• Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases

  2022cites this paper
• Chronic oligodendrocyte injury in central nervous system pathologies

  2022cites this paper
• Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?

  2022cites this paper
• Postmortem quantitative MRI disentangles histological lesion types in multiple sclerosis

  2022cites this paper
• Age-related injury responses of human oligodendrocytes to metabolic insults: link to BCL-2 and autophagy pathways

  2021cites this paper
• Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody‐associated disease

  2021cites this paper
• Myelinoclastic diffuse sclerosis (Schilder’s disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar punctures

  2019cites this paper
• The history of neuromyelitis optica. Part 2: ‘Spinal amaurosis’, or how it all began

  2019cites this paper
• Historique de la sclérose en plaques

  2019cites this paper
• Spatiotemporal distribution of fibrinogen in marmoset and human inflammatory demyelination

  2018cites this paper
• Dose-Response Relationship of EAE Clinical Severity in a MOG 35-55 Mouse Model : A Pilot Study

  2018cites this paper
• Defining distinct features of anti-MOG antibody associated central nervous system demyelination

  2018cites this paper
• Dynamic changes and molecular analysis of cell death in the spinal cord of SJL mice infected with the BeAn strain of Theiler’s murine encephalomyelitis virus

  2018cites this paper
• Ketogenic diets attenuate cyclooxygenase and lipoxygenase gene expression in multiple sclerosis

  2018cites this paper
• Lower Arterial Cross-Sectional Area of Carotid and Vertebral Arteries and Higher Frequency of Secondary Neck Vessels Are Associated with Multiple Sclerosis

  2018cites this paper
• Distinct patterns of glia repair and remyelination in antibody‐mediated demyelination models of multiple sclerosis and neuromyelitis optica

  2018cites this paper
• Modulating inflammation and neuroprotection in multiple sclerosis

  2018cites this paper
• Multiple sclerosis: Serum anti-CNS autoantibodies

  2018cites this paper
• Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis

  2017influential citation
• Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis

  2017influential citation
• Sublethal oligodendrocyte injury: A reversible condition in multiple sclerosis?

  2017cites this paper
• Female sex steroids and glia cells: Impact on multiple sclerosis lesion formation and fine tuning of the local neurodegenerative cellular network.

  2016cites this paper
• Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica

  2016cites this paper
• LRP1 expression in microglia is protective during CNS autoimmunity

  2016cites this paper
• Magnetic resonance diffusion tensor imaging for occult lesion detection in multiple sclerosis

  2016cites this paper
• MECHANISMS OF NEURODEGENERATION IN MULTIPLE SCLEROSIS: PREMISE FOR NEUROPROTECTION?

  2016cites this paper
• Role of T and B cells in pathogenesis of multiple sclerosis

  2016cites this paper
• Multiple Sclerosis and Allied Demyelinating Diseases

  2016cites this paper
• Mutagenesis of the Aquaporin 4 Extracellular Domains Defines Restricted Binding Patterns of Pathogenic Neuromyelitis Optica IgG

  2015cites this paper
• This information is current as Model of Multiple Sclerosis Drive Neuroinflammation in an Animal B Cell Antigen Presentation Is Sufficient To and

  2015cites this paper
• CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes

  2015cites this paper
• Semaphorins and Neurodegenerative Disorders

  2015cites this paper
• B Cell Antigen Presentation Is Sufficient To Drive Neuroinflammation in an Animal Model of Multiple Sclerosis

  2014cites this paper
• New regulatory CD19(+)CD25(+) B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids.

  2014cites this paper
• Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitis

  2014cites this paper
• Structure, Size, and Solubility of Antigen Arrays Determines Efficacy in Experimental Autoimmune Encephalomyelitis

  2014cites this paper
• Monoclonal Antibodies as Disease Modifying Therapy in Multiple Sclerosis

  2013cites this paper
• Tumefactive MS lesions under fingolimod

  2013cites this paper
• Antigen microarrays for the study of autoimmune diseases.

  2013cites this paper
• Influence of Peripheral inflammation on the progression of multiple sclerosis: evidence from the clinic and experimental animal models.

  2013cites this paper
• CD8+ T cells in multiple sclerosis

  2013cites this paper
• Oligodendrocytes and the early multiple sclerosis lesion

  2012cites this paper
• Reibergram and oligoclonal bands in diagnosis of multiple sclerosis.

  2012cites this paper
• Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

  2012cites this paper
• Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor‐mediated ERK1/2 activation to accelerate remyelination

  2012cites this paper
• Primary oligodendrocyte death does not elicit anti-CNS immunity

  2012cites this paper
• Biochemical markers of autoimmune diseases of the nervous system.

  2012cites this paper
• Microarray analysis on archival multiple sclerosis tissue: Pathogenic authenticity outweighs technical obstacles

  2012cites this paper
• The ambivalent role of apoptosis in experimental autoimmune encephalomyelitis and multiple sclerosis.

  2012cites this paper
• Acute demyelinating disorders: emergencies and management.

  2012cites this paper
• Elektronenmikroskopische Studien zur Bluthirnschranke

  2012cites this paper
• Epidémiologie de la sclérose en plaques en France

  2012influential citation
• CNS response to a second pro-inflammatory event depends on whether the primary demyelinating lesion is active or resolved.

  2012cites this paper
• Cladribine: Mode of Action and Implications for Treatment of Multiple Sclerosis

  2011cites this paper
• Das lymphozytäre Entzündungsinfiltrat in Multiple-Sklerose-Läsionen: Immunhistochemische Analyse im Bezug auf immunopathogenetische Subtypen und Läsionsaktivitäten

  2011cites this paper
• The immunopathophysiology of multiple sclerosis.

  2011cites this paper
• Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis

  2011cites this paper
• Neurofilament Changes in Multiple Sclerosis

  2011cites this paper
• BDNF Val66Met polymorphism and brain volumes in multiple sclerosis

  2011cites this paper
• The importance of clinical trials in unraveling the mysteries of multiple sclerosis.

  2011cites this paper
• Aspects of multiple sclerosis that relate to experimental therapeutics

  2011cites this paper
• Neuropsychological, medical and rehabilitative management of persons with multiple sclerosis

  2011cites this paper
• SPARC expression during development and inflammation at the blood-brain barrier

  2011cites this paper
• The immuno-pathophysiology of multiple sclerosis

  2011cites this paper
• Development of a research agenda for evaluation of interventional therapies for chronic cerebrospinal venous insufficiency: proceedings from a multidisciplinary research consensus panel.

  2011cites this paper
• Current concepts in the neuropathology and pathogenesis of multiple sclerosis.

  2010cites this paper
• Autoimmune Versus Oligodendrogliopathy: The Pathogenesis of Multiple Sclerosis

  2010cites this paper
• T-cells in multiple sclerosis.

  2010cites this paper
• Was verursacht Multiple Sklerose?

  2010cites this paper
• xvi 1 1 inFLAmmAtion And AutoimmunitY : A nerVous sYstem perspeCtiVe

  2010cites this paper
• Clinical immunological and immunogenetical aspects of neurological diseases.

  2010cites this paper
• Apoptosis of Oligodendrocytes and Post-Translational Modifications of Myelin Basic Protein in Multiple Sclerosis: Possible Role for the Early Stages of Multiple Sclerosis

  2010cites this paper
• CXCL13: A Prognostic Marker in Multiple Sclerosis

  2010cites this paper
• Current Concepts in the Neuropathology and Pathogenesis of Multiple Sclerosis

  2010cites this paper
• Establishment and Applications of a Multiple Sclerosis Biobank Analysis of Biomarkers and Therapeutic Complications in MS

  2010cites this paper
• Chapter 37 – Optic neuritis

  2010cites this paper
• Cognition in multiple sclerosis: a review of neuropsychological and fMRI research.

  2009cites this paper
• An in vitro model for de‐ and remyelination using lysophosphatidyl choline in rodent whole brain spheroid cultures

  2009cites this paper
• Gender differences in the histopathology of MS?

  2009cites this paper
• The pathological spectrum of CNS inflammatory demyelinating diseases

  2009cites this paper
• Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study

  2009cites this paper
• Low-density lipoprotein receptor-related protein 1 is an essential receptor for myelin phagocytosis

  2009cites this paper
• Demyelinating Disorders of the Central Nervous System

  2009cites this paper
• Gene expression and variation in multiple sclerosis.

  2009cites this paper
• Cortical pathology in multiple sclerosis

  2008cites this paper
• Pathological heterogeneity of idiopathic central nervous system inflammatory demyelinating disorders.

  2008cites this paper
• The high producer variant of the Fc-receptor like-3 (FCRL3) gene is involved in protection against multiple sclerosis.

  2008cites this paper
• Simplified MRI prediction of clinically definite multiple sclerosis: a stepping stone towards treatment criteria?

  2008cites this paper
• Hypothesis of double polarization.

  2008cites this paper
• Neuromyelitis optica: eine mit Aquaporin-4-Antikörpern assoziierte nosologische Entität

  2008cites this paper
• Generation and potential biomedical applications of embryonic stem cell-derived glial precursors.

  2008cites this paper
• Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases

  2008cites this paper
• Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis

  2008cites this paper
• Brain atrophy assessment in multiple sclerosis: importance and limitations.

  2008cites this paper